Health

Antengene Publishes Preclinical Research Paper on CD73 Small Molecule Inhibitor ATG-037 Combined with Selinexor in Cancer Gene Therapy

SHANGHAI and HONG KONG, Sept. 14, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune ...

2026-09-14 12:38

Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand

MELBOURNE, Australia, Sept. 14, 2026 /PRNewswire/ -- Sorbent Paper Company Pty Ltd ("Sorbent") has signed an agreement with Kenvue's Singaporean subsidiary to acquire its Stayfree and Carefree feminine care business in Australia and New Zealand. Following completion of the transaction, the busine...

2026-09-14 11:58 208

FDA Approves Telix's Brain Cancer Imaging Drug Pixclara

* Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer). * Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from treatment-related change in adults and pediatric patients. * FET-PET imaging is recom...

2026-09-14 06:56 936

IonOpticks launches Aurora Series® 5 and new CoreJet™ emitter technology, advancing robust nano-LC for routine proteomics research.

New CoreJet™ integrated emitter technology and a redesigned nanoZero® union combine proven Aurora Series® performance with a step-change in robustness, lowering cost per sample without compromising the depth and sensitivity researchers depend on. MELBOURNE, Australia, Sept. 14, 2026 /PRNewswire/...

2026-09-14 06:30 1416

Agenda for the 4th Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium Officially Released

Leading Experts from Medicine, Research, Industry and Investment Revealed HONG KONG, Sept. 11, 2026 /PRNewswire/ -- Scheduled for September 22–23, 2026, the 4th Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium will be held at the Charles K. Kao Auditorium in Hong ...

2026-09-11 19:24 6085

The Rockefeller Foundation and TPC Announce Strategic Collaboration to Advance New Models of Impact Across Asia

SINGAPORE, Sept. 11, 2026 /PRNewswire/ -- The Rockefeller Foundation and TPC (Tsao Pao Chee), together with NO.17 Foundation, today announced a Memorandum of Understanding (MoU) to explore a strategic collaboration to address interconnected challenges across land, food, health and energy in Asia....

2026-09-11 16:30 3910

Neutech Group's "Education-Healthcare-Wellness" Strategy Lands in Dandong

Neuhealth·Phoenix Valley All-Age Wellness & Healing Destination Officially Opens HONG KONG and DALIAN, China, Sept. 11, 2026 /PRNewswire/ -- On September 10, 2026, at the foot of Phoenix Mountain in Dandong, Liaoning, an Innovation and Development Exchange on the Wellness & Healing Industry was h...

2026-09-11 16:21 2109

Illuminate Medispa Marks New Milestone as It Advances a Holistic Approach to Aesthetics and Wellness in Singapore

The Dempsey Hill medical aesthetics and wellness destination continues its growth with a focus on personalised care, advanced technologies and an integrated approach to wellbeing. SINGAPORE, Sept. 11, 2026 /PRNewswire/ -- Illuminate Medispa is marking a new milestone in its growth journey as it ...

2026-09-11 13:49 2673

THE GALIEN FOUNDATION ANNOUNCES INAUGURAL PRIX GALIEN JAPAN FORUM & AWARDS CEREMONY

Prestigious Life Sciences Platform and Awards Launch in Tokyo to Celebrate Breakthrough Innovation TOKYO, Sept. 11, 2026 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced that it will host the first Prix Galie...

2026-09-11 08:00 1890

Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults

Phase 3 study demonstrates benefits of the first influenza vaccine to combine three proven approaches to enhancing protection for older adults in a single vaccine. MAIDENHEAD, United Kingdom, Sept. 11, 2026 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL; USOTC: CSLLY), today announced ...

2026-09-11 06:51 3113

Family Offices are Becoming One of the Most Powerful Forces in Hospitality Investment in Asia-Pacific, Questex's IHIF Asia Highlights Growing Influence of Private Capital

HONG KONG, Sept. 11, 2026 /PRNewswire/ -- Hospitality has become the top real estate asset class for family office capital in Asia-Pacific, highlighting the sector's growing appeal to private investors.IHIF Asia supports this increasingly important investor segment wit...

2026-09-11 06:00 2582

ABEC Opens New Manufacturing Facility in Wilson, North Carolina

Grand Opening Ceremony Scheduled for September 24, 2026 BETHLEHEM, Pa., Sept. 10, 2026 /PRNewswire/ -- ABEC, a global leader in customized solutions and services for biopharmaceutical manufacturing, today announced the grand opening of its newest manufacturing facility in Wilson, North Carolina....

2026-09-10 23:11 1881

Dr Hanan H. Balkhy Launches Candidacy for WHO Director-General, Pledges "A WHO the World Can Count On"

* Nominated by the Kingdom of Saudi Arabia * A physician trained in Saudi Arabia and the United States, with more than 30 years of experience spanning clinical medicine, academic research and international public health leadership * WHO Regional Director for the Eastern Mediterranean sets ou...

2026-09-10 20:55 1910

ZEISS announces commercial availability of bitoric hydrophobic monofocal IOL - the ZEISS AT LUCIA toric 721P

Launching at ESCRS in London, the world's first bitoric hydrophobic monofocal intraocular lens with a non-constant asphericity profile design expands the ZEISS LUCIA Family to treat cataracts while simultaneously correcting astigmatism. JENA, Germany, Sept. 10, 2026 /PRNewswire/ -- ZEISS Medical...

2026-09-10 20:00 1553

/C O R R E C T I O N -- CordenPharma/

In the news release, CordenPharma Boosts Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Per Year, issued 10-Sep-2026 by CordenPharma over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details ...

2026-09-10 19:28 1645

Nuritas Appoints Former Unilever North America President Kees Kruythoff as Board Chair

The 30-year industry veteran brings global scaling and commercialization expertise to biotech leader Nuritas. DUBLIN, Sept. 10, 2026 /PRNewswire/ -- Nuritas , a global leader in bi...

2026-09-10 19:00 1936

Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing

SINGAPORE, Sept. 10, 2026 /PRNewswire/ -- Novo Holdings, a leading global healthcare and life sciences investor, today announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd. ("ForYou Medical"), a China-based contract development and manufacturing organisation (CDMO)...

2026-09-10 15:00 7011

AXA and BytePlus sign strategic MOU Pioneering AI-Driven Transformation across insurance value chain

Partnership focuses on co-innovating industry-specific solutions, enhancing customer intelligence, and accelerating operational innovation HONG KONG, Sept. 10, 2026 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") announced the signing of a Memorandum of Understanding ("MOU") with BytePlus Pte. L...

2026-09-10 12:23 1605

BGI Genomics Launches "Digital Life Twin" Framework to Power Proactive Health

SHENZHEN, China, Sept. 9, 2026 /PRNewswire/ -- Commemorating BGI Group's 27th anniversary, BGI Genomics today introduced its Digital Life Twin framework alongside an advanced multi-omics diagnostic portfolio at the 2026 Global New Product Launch Event. Grounded in over two decades of population-s...

2026-09-09 21:45 2283

First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA

BEIJING and BRIDGEWATER, Mass., Sept. 9, 2026 /PRNewswire/ -- Gan&Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan&Lee) announced that the first participant has been dosed in a First-In-Human (FIH) Phase 1 study of GZC8072 tablets, a novel ultra-long-acting oral peptide GLP-1 RA form...

2026-09-09 21:00 4011
12345 ... 539